Radiopharm Theranostics Ltd (RADX) Form 6-K — Oct 20, 2026
Radiopharm Theranostics filed a 6-K reporting four ASX Change of Director's Interest Notices dated 16 October 2026.
Key figures
- Unquoted options issued
- 140028000
- Ordinary shares outstanding
- 4710882790
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.